Facile development of copper ferrite nanospheres for UV light-driven photocatalytic degradation of cloxacillin sodium

Literature Information

Publication Date 2023-11-23
DOI 10.1039/D3MA00677H
Impact Factor 0
Authors

Faheem Haider, Adnan Ashraf, Saeed Ahmed, Khalid Mujasam Batoo, Waseeq Ahmad Siddiqui, Muhammad Imran, Muhammad Asam Raza, Muhammad Pervaiz, Sajjad Hussain


View Original

Abstract

Copper ferrite nanoparticles (CuFe2O4 NPs) have multiple applications in various fields. Herein, a co-precipitation method under mild basic conditions has been used to develop CuFe2O4 NPs. The obtained precipitates were annealed at 500 °C for 4 hours to form copper ferrite. The synthesis of CuFe2O4 NPs was initially confirmed by UV-visible spectroscopy. The presence of specific functional groups like Fe–O was found at 593 cm−1 using Fourier transform infrared spectroscopy. The tetrahedral crystal structure for the CuFe2O4 NPs has been confirmed by X-ray diffraction analysis. The nanosphere-like morphology was confirmed by field emission scanning electron microscopy and the average calculated size of the nanoparticles is ∼45 nm and the pHPZC for the CuFe2O4 NPs is 6.67. The synthesized CuFe2O4 NPs were used for UV light-mediated degradation of cloxacillin sodium (CLX). The degradation of CLX was optimized under different sets of conditions including times of exposure of the drug with the catalyst under UV light, pH values, concentrations, and dosages of the catalyst. The total organic carbon (TOC) confirms 39% degradation of the drug, which is converted into inorganic carbon (IC) and in line with other experimental results. This study provides new insight into the use of copper ferrite to overcome pharmaceutical pollution of water bodies.

Related Literature

Novel butane sulfonic acid-functionalized core–shell magnetic nanocatalysts for ultrasound-assisted coumarin synthesis

Somayeh Soleimani-Amiri, Yasaman Salemi

2023-12-27 Paper

DOI: 10.1039/D3NJ04912D

Back cover

2024-01-31 Cover

DOI: 10.1039/D4TB90021A

Contents list

2024-01-17 Front/Back Matter

DOI: 10.1039/D4TB90013H

Electrogelated drug-embedded silk/gelatin/rGO degradable electrode for anti-inflammatory applications in brain-implant systems

Zhen-Kai Lin, Jing-Syu Lin, Zih-Huei Chen, Hung-Wei Cheng, Wei-Chen Huang

2024-01-02 Paper

DOI: 10.1039/D3TB02715E

Front cover

2024-01-17 Cover

DOI: 10.1039/D4TB90011A

A terbium-functionalized ZIF-8 nanosensor for rapid and sensitive detection of an anthrax spore biomarker

Xurong Zuo, Pengfei Liu, Qinhao Sun, Jiahui Huang, Yuwei Zhang, Xuecheng Zhu, Runqi Chen

2023-12-18 Paper

DOI: 10.1039/D3NJ04760A

Back cover

2024-01-29 Cover

DOI: 10.1039/D4NJ90016B

Contents list

2024-01-22 Front/Back Matter

DOI: 10.1039/D4NJ90012J

A review of nanomaterials for biosensing applications

Lei Li, Tianshu Wang, Yuting Zhong, Ruyi Li, Wei Deng, Xuanyu Xiao, Yuanyuan Xu, Jieyu Zhang, Xuefeng Hu, Yunbing Wang

2023-12-21 Review Article

DOI: 10.1039/D3TB02648E

Difunctionalization of alkenes proceeding with radical 1,2-alkynyl migration in batch and continuous-flow modes

Ziren Mao, Yiliang Zhou, Jingming Zhang, Chengkou Liu, Chang-Sheng Wang, Xiaobing Yang, Hong Qin, Zheng Fang

2023-12-02 Paper

DOI: 10.1039/D3NJ05081E

You might also like

Compound Q&A

What industries use 4-(4-tert-Butylphenyl)-1H-pyrazol-3-amine (CAS: 1015845-73-4)?

4-(4-tert-Butylphenyl)-1H-pyrazol-3-amine finds applications in various industri...

1015845-73-44-(4-tert-Butylpheny...
Compound Q&A

What industries use H3TATAB (CAS: 63557-10-8)?

H3TATAB is used in the pharmaceutical industry for the synthesis of certain orga...

63557-10-8H3TATAB
Compound Q&A

What are the main uses of 1-Ethyl-3-fluorobenzene (CAS: 696-39-9)?

1-Ethyl-3-fluorobenzene (CAS: 696-39-9) is primarily used as a precursor in the ...

696-39-91-Ethyl-3-fluorobenz...
Compound Q&A

What are the main uses of 1-(tert-Butoxycarbonyl)-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid (CAS: 851484-94-1)?

1-(tert-Butoxycarbonyl)-4-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid is prim...

851484-94-11-(tert-Butoxycarbon...
Compound Q&A

What are the physical and chemical properties of 1-Cyclobutyl-4-piperidinone (CAS: 359880-05-0)?

1-Cyclobutyl-4-piperidinone (CAS: 359880-05-0) is a colorless or white crystalli...

359880-05-01-Cyclobutyl-4-piper...
Compound Q&A

What is Pyridine-2,6-dicarboxylic acid mono-tert-butyl ester (CAS: 575433-76-0)?

Pyridine-2,6-dicarboxylic acid mono-tert-butyl ester (CAS: 575433-76-0) is a che...

575433-76-0Pyridine-2,6-dicarbo...
Compound Q&A

What is the market or research trend for 2,3-Difluorophenylalanine (CAS: 236754-62-4)?

The market for 2,3-Difluorophenylalanine (CAS: 236754-62-4) is growing with incr...

236754-62-42,3-Difluorophenylal...
Compound Q&A

How is (2-Hydroxy-1-naphthyl)boronic acid (CAS: 898257-48-2) typically synthesized?

(2-Hydroxy-1-naphthyl)boronic acid can be synthesized through the reduction of 2...

898257-48-2(2-Hydroxy-1-naphthy...
1315351-28-0tert-Butyl (5-bromo-...
Compound Q&A

Are there alternatives to 5,7-Dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl beta-D-glucopyranoside (CAS: 19833-12-6) in synthesis?

While 5,7-Dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)-4H-chromen-3-yl beta-D-gluc...

19833-12-65,7-Dihydroxy-4-oxo-...

Source Journal

Materials Advances

Materials Advances
CiteScore: 0
Self-citation Rate: 0%
Articles per Year: 0

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.